Ziegler D - Search Results

1

Efficacy and safety of lacosamide in painful diabetic neuropathy.

Ziegler D, Hidvégi T, Gurieva I, Bongardt S, Freynhagen R, Sen D, Sommerville K; Lacosamide SP743 Study Group. Ziegler D, et al. Diabetes Care. 2010 Apr;33(4):839-41. doi: 10.2337/dc09-1578. Epub 2010 Jan 12. Diabetes Care. 2010. PMID: 20067958 Free PMC article. Clinical Trial.

2

Clinical trials for drugs against diabetic neuropathy: can we combine scientific needs with clinical practicalities?

Ziegler D, Luft D. Ziegler D, et al. Int Rev Neurobiol. 2002;50:431-63. doi: 10.1016/s0074-7742(02)50085-4. Int Rev Neurobiol. 2002. PMID: 12198820 Review.

3

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D; SYDNEY Trial Study Group. Ametov AS, et al. Among authors: ziegler d. Diabetes Care. 2003 Mar;26(3):770-6. doi: 10.2337/diacare.26.3.770. Diabetes Care. 2003. PMID: 12610036 Clinical Trial.

4

Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy.

Ziegler D, Sohr CG, Nourooz-Zadeh J. Ziegler D, et al. Diabetes Care. 2004 Sep;27(9):2178-83. doi: 10.2337/diacare.27.9.2178. Diabetes Care. 2004. PMID: 15333481

5

Validation of a novel screening device (NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy.

Ziegler D, Siekierka-Kleiser E, Meyer B, Schweers M. Ziegler D, et al. Diabetes Care. 2005 May;28(5):1169-74. doi: 10.2337/diacare.28.5.1169. Diabetes Care. 2005. PMID: 15855584 Clinical Trial.

6

Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.

Ziegler D. Ziegler D. Treat Endocrinol. 2004;3(3):173-89. doi: 10.2165/00024677-200403030-00005. Treat Endocrinol. 2004. PMID: 16026113 Review.

7

New perspectives on the management of diabetic peripheral neuropathic pain.

Jensen TS, Backonja MM, Hernández Jiménez S, Tesfaye S, Valensi P, Ziegler D. Jensen TS, et al. Among authors: ziegler d. Diab Vasc Dis Res. 2006 Sep;3(2):108-19. doi: 10.3132/dvdr.2006.013. Diab Vasc Dis Res. 2006. PMID: 17058631 Free article. Review.

8

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Ziegler D, et al. Diabetes Care. 2006 Nov;29(11):2365-70. doi: 10.2337/dc06-1216. Diabetes Care. 2006. PMID: 17065669 Clinical Trial.

9

Treatment of diabetic polyneuropathy: Update 2006.

Ziegler D. Ziegler D. Ann N Y Acad Sci. 2006 Nov;1084:250-66. doi: 10.1196/annals.1372.008. Ann N Y Acad Sci. 2006. PMID: 17151306 Review.

10

Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.

Ziegler D, Pritchett YL, Wang F, Desaiah D, Robinson MJ, Hall JA, Chappell AS. Ziegler D, et al. Diabetes Care. 2007 Mar;30(3):664-9. doi: 10.2337/dc06-2009. Diabetes Care. 2007. PMID: 17327338 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,307 results

Search Page